Delivery Order SPE2DB25D3012-SPE2DB25FWXPX
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 30 mg/ml vials. The contract has a total ceiling value of $1,344.56 and a completion date of February 3, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/mL vials. The contract has a ceiling value of $1,028.16 and an ultimate completion date of November 22, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order valued at $2,909.40 with a firm fixed price and an ultimate completion date of June 11, 2025. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,357.72, is a firm fixed-price delivery order for the supply of Ketorolac 30 mg/mL vials. The contract has a period of performance through June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ketorolac 30 mg/ml vial. The contract has a firm fixed price, is not set aside, and has a ceiling value of $4,102.92. The ultimate completion date is October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,358,076 milliliters of Ketorolac 30 mg/ml vials. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $16,066.14 and a completion date of April 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Ketorolac 30 mg/mL vials. The contract has a ceiling value of $2,125.73 and a completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to supply a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $2,530.98 to provide 4564108769 ketorolac 30 mg/ml vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ketorolac 30 mg/mL vials. The $3,134.03 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, which has no set-aside designation, has an ultimate completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract...